Arbutus Biopharma Corp (NASDAQ:ABUS)

3.29
Delayed Data
As of Apr 09
 0.00 / 0.00%
Today’s Change
1.00
Today|||52-Week Range
9.02
-7.32%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$317.9M

Company Description

Arbutus Biopharma Corp. is a biopharmaceutical company. It engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company was founded in 2007 and is headquartered in Warminster, PA.

Contact Information

Arbutus Biopharma Corp.
701 Veterans Circle
Warminster Pennsylvania 18974
P:(267) 469-0914
Investor Relations:

Employees

Shareholders

Mutual fund holders5.70%
Individual stakeholders23.63%
Other institutional20.81%

Top Executives

William H. CollierPresident, Chief Executive Officer & Director
David C. HastingsChief Financial & Accounting Officer
Michael J. SofiaChief Scientific Officer
Elizabeth HowardChief Compliance Officer, EVP & General Counsel
Michael J. McElhaughChief Business Officer